If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Regulatory News (ABDN)

Share Price Information for Abrdn (ABDN)

Share Price is delayed by 15 minutes
Get Live Data
258.40    4.80 (1.89%)
Bid:
257.40
Ask:
257.60
Spread: 0.20 (0.078%)
Market Cap: £4.62b
ABDN Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Share Chart

Director/PDMR Shareholding

10 Apr 2025 10:12

RNS Number : 5099E
Aberdeen Group PLC
10 April 2025
 

Aberdeen Group plc

('the Company')

 

Notification of Interests of Person Discharging Managerial Responsibilities (PDMR)

 

The notification set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

 

On 8 April 2024, the Company granted to Jason Windsor, Chief Executive Officer, an award under the terms of the Company's Deferred Share Plan ("Award") as a result of the deferred portion of his Annual Bonus award for 2023. The Award was granted in the form of a conditional award to acquire ordinary shares in the Company, subject to the rules of the Deferred Share Plan, vesting in equal one-third tranches on the first, second and third anniversaries of the Grant Date.

 

On the same date the Company also granted to Mr Windsor a buyout award to compensate for the performance year 2023 bonus that he forfeited on leaving his previous employer. The Award was granted in the form of a conditional award to acquire shares in the Company, vesting in equal one-third tranches on the first, second and third anniversaries of the Grant Date. This Award was granted under a one-off award arrangement established under Listing Rule 9.3.2(2) in order to facilitate the recruitment of Mr Windsor.

 

Details of these grants are set out in the 2024 Annual Report and Accounts.

 

During the period from the Grant Date to the Vesting Date the Awards carried a right to receive an amount in additional shares equal in value to any dividends that would have been paid on such shares in respect of the portion of the Award that is released. The dividend equivalent shares are reflected in the vested portion of the Awards. 

 

Details in relation to the acquired shares from the vesting of the Awards are summarised as follows:

 

Jason Windsor

Deferred Share Award

Date of vesting

08/04/2025

08/04/2025

Date of notification

09/04/2025

09/04/2025

Shares vested

9,056

105,585

Shares sold to cover tax

4,257

49,625

Shares acquired

4,799

55,960

Share price at vesting

£1.3070

£1.3070

 

10 April 2025

 

LEI: 0TMBS544NMO7GLCE7H90

Classification: 3.1. Additional regulated information required to be disclosed under the laws of the United Kingdom

 

Enquiries:

 

 

Rose Edwards

Deputy Group Company Secretary

 

+44 (0)7971 188 901

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFIFLASIIILIE
Date   Source Headline
2nd Jan 20253:33 pmRNSHolding(s) in Company
2nd Jan 202511:23 amRNSTotal Voting Rights
23rd Dec 20242:40 pmRNSHolding(s) in Company
19th Dec 202410:10 amRNSDirector/PDMR Shareholding
16th Dec 20245:05 pmRNSHolding(s) in Company
16th Dec 20244:30 pmRNSDirectorate Change
10th Dec 202410:19 amRNSHolding(s) in Company
9th Dec 20247:00 amRNSHolding(s) in Company
6th Dec 202411:35 amRNSForm 8.3 - Tritax Eurobox plc
3rd Dec 20249:40 amRNSTR-1:Notification of major holdings
2nd Dec 20249:11 amRNSTotal Voting Rights
28th Nov 202412:44 pmRNSForm 8.3 - Direct Line Insurance Group plc
28th Nov 202412:40 pmRNSForm 8.3 - Aviva plc
27th Nov 202411:00 amRNSHolding(s) in Company
26th Nov 20244:56 pmRNSHolding(s) in Company
26th Nov 202412:40 pmRNSForm 8.3 - Volex plc
18th Nov 202412:50 pmRNSForm 8.3 - Volex plc
18th Nov 202412:48 pmRNSForm 8.3 - TT Electronics plc
18th Nov 202411:06 amRNSForm 8 (DD) - SEGRO plc
15th Nov 202410:47 amRNSForm 8 (DD) - SEGRO plc
13th Nov 20242:38 pmRNSHolding(s) in Company
12th Nov 202410:26 amRNSForm 8 (DD) - SEGRO plc
12th Nov 20247:00 amRNSHolding(s) in Company
8th Nov 202410:15 amRNSForm 8 (DD) - SEGRO plc
5th Nov 202411:13 amRNSForm 8 (DD) - SEGRO plc
4th Nov 20249:47 amRNSForm 8 (DD) - SEGRO plc
1st Nov 202410:20 amRNSTotal Voting Rights
1st Nov 20249:44 amRNSForm 8 (DD) - SEGRO plc
28th Oct 202410:53 amRNSForm 8 (DD) - SEGRO plc
24th Oct 20247:00 amRNSQ3 2024 AUMA & Flows Trading Update
23rd Oct 202411:07 amRNSForm 8 (DD) - SEGRO plc
22nd Oct 20245:04 pmRNSDirector Declaration
21st Oct 202411:02 amRNSForm 8 (DD) - SEGRO plc
18th Oct 20242:09 pmRNSBlock listing Interim Review
16th Oct 202411:02 amRNSForm 8 (DD) - SEGRO plc
15th Oct 20248:38 amRNSHolding(s) in Company
9th Oct 20243:30 pmRNSHolding(s) in Company
9th Oct 20241:41 pmRNSHolding(s) in Company
9th Oct 202410:12 amRNSForm 8 (DD) - SEGRO plc
1st Oct 202410:20 amRNSHolding(s) in Company
1st Oct 20249:45 amRNSTotal Voting Rights
30th Sep 20245:23 pmRNSHolding(s) in Company
30th Sep 202410:53 amRNSForm 8 (DD) - SEGRO plc
27th Sep 20243:30 pmRNSNotification of Interests of Executive Directors
27th Sep 202410:40 amRNSForm 8 (DD) - SEGRO plc
27th Sep 20247:00 amRNSHolding(s) in Company
23rd Sep 202411:31 amRNSForm 8 (DD) - SEGRO plc
20th Sep 202411:13 amRNSForm 8 (DD) - SEGRO plc
18th Sep 202411:05 amRNSForm 8 (DD) - SEGRO plc
17th Sep 202411:26 amRNSForm 8 (DD) - SEGRO plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.